Design Therapeutics, Inc.
Design Therapeutics, Inc.（DSGN）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · DSGN · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Design Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
DSGN 季度内部人买卖趋势
DSGN 内幕交易卖出 · DSGN 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · DSGN CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
DSGN 高管卖出股份 · DSGN 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 13, 2025 | William Arsani Director | Sale | 345,000 | $1.81M⚡ | Form 4 |
| Aug 13, 2025 | William Arsani Director | Sale | 217,627 | $1.14M⚡ | Form 4 |
| Dec 18, 2024 | Prasad Deepa Director | Sale | 3,806 | $24K | Form 4 |
| Aug 9, 2024 | William Arsani Director | Sale | 814,874 | $3.46M⚡ | Form 4 |
| Mar 25, 2024 | Schmid John P. Director | Purchase | 17,809 | $67K | Form 4 |
| Mar 22, 2024 | Schmid John P. Director | Purchase | 9,156 | $33K | Form 4 |
| Mar 25, 2024 | Berger Heather A. Director | Purchase | 1,300 | $5K | Form 4 |
| Sep 29, 2023 | LAPPE RODNEY W Director | Purchase | 21,000 | $49K | Form 4 |
| Aug 29, 2023 | Prasad Deepa Director | Purchase | 12,000 | $28K | Form 4 |
| Aug 29, 2023 | William Arsani Director | Purchase | 1,960,000 | $4.78M⚡ | Form 4 |
| Aug 28, 2023 | William Arsani Director | Purchase | 275,000 | $591K | Form 4 |
| Dec 20, 2022 | Siffert Joao MD President and CEO | Purchase | 6,300 | $53K | Form 4 |
| Dec 19, 2022 | Siffert Joao MD President and CEO | Purchase | 1,150 | $10K | Form 4 |
| Dec 20, 2022 | George Simeon Director | Purchase | 40,000 | $325K | Form 4 |
| Dec 19, 2022 | George Simeon Director | Purchase | 360,000 | $3.11M⚡ | Form 4 |
| Dec 16, 2022 | George Simeon Director | Purchase | 500,000 | $4.14M⚡ | Form 4 |
| Dec 20, 2022 | SR One Capital Fund I Aggregator LP Director | Purchase | 40,000 | $325K | Form 4 |
| Dec 19, 2022 | SR One Capital Fund I Aggregator LP Director | Purchase | 360,000 | $3.11M⚡ | Form 4 |
| Dec 16, 2022 | SR One Capital Fund I Aggregator LP Director | Purchase | 500,000 | $4.14M⚡ | Form 4 |
| Dec 9, 2022 | LAPPE RODNEY W Director | Purchase | 15,000 | $119K | Form 4 |
| Mar 21, 2022 | William Arsani Director | Purchase | 25,000 | $475K | Form 4 |
| Mar 18, 2022 | Xu Stella Director | Sale | 13,200 | $268K | Form 4 |
| Mar 16, 2022 | Prasad Deepa Director | Other | 11,806 | — | Form 4 |
| Aug 31, 2021 | William Arsani Director | Purchase | 40,000 | $618K | Form 4 |
SR One Capital Fund I Aggregator LP
Director
日期
Dec 20
股数
40,000
均价
$8.14
总金额
$325K
SR One Capital Fund I Aggregator LP
Director
日期
Dec 19
股数
360,000
均价
$8.63
总金额
$3.11M ⚡
SR One Capital Fund I Aggregator LP
Director
日期
Dec 16
股数
500,000
均价
$8.28
总金额
$4.14M ⚡
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 DSGN 内幕交易
DSGN 内幕交易
Design Therapeutics, Inc.（DSGN）内幕交易数据来源于公司内部人（包括William Arsani (Director)）提交的SEC Form 4申报文件。过去12个月内，1位内部人向SEC提交了交易申报。DSGN内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Design Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
DSGN 内幕交易 · 5个问题Design Therapeutics, Inc.（DSGN）的内部人包括高管和董事，如William Arsani (Director)等。过去12个月内，1位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026